Belarus Pharmaceuticals and Healthcare Report Q2 2015

BMI Research
March 18, 2015
88 Pages - SKU: BMI5496801
Countries covered: Belarus

Belarus Pharmaceuticals and Healthcare Report Q2 2015

BMI View: The volatility of the Belarusian rouble and high inflation will hurt consumer incomes and therefore the growth outlook of the pharmaceutical market over the next two years. Furthermore, increased scrutiny by President Lukashenko over pharmaceutical imports indicates that Belarus may follow neighbouring Russia in instituting measures that favour the domestic industry and restrict the market for pharmaceutical imports.

Headline Expenditure Projections

Pharmaceuticals: BYR10,223bn in 2014 (USD998mn) to BYR12,101bn (USD869mn) in 2015; +18.4% in local currency terms and -12.9% in US dollar terms.

Healthcare: BYR36,100bn (USD3.50bn) in 2013 to BYR42,419bn (USD3.05bn) in 2015; +17.5% in local currency terms and -13.5% in US dollar terms.



More Prescription Drugs reports by BMI Research

Zimbabwe Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Zimbabwe Pharmaceuticals and Healthcare Report Q2 2015BMI View: Zimbabwe's Treasury has failed to assign sufficient funds to the health sector in its 2015 National Budget, ...
United Kingdom Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
United Kingdom Pharmaceuticals and Healthcare Report Q2 2015BMI View: The ageing population will have an unprecedented impact on the demand of healthcare and therapeutics in ...
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2015BMI View: Access to healthcare in Sudan and South Sudan is poor and drug shortages are ...
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015BMI View: Sri Lanka's strong pharmaceutical market is backed by a committed government and plans to deliver improved ...
See all reports like this >>

More Belarus Prescription Drugs reports

Pharmaceuticals and Healthcare Report - Belarus Q4 2014 by BMI Research
Pharmaceuticals and Healthcare Report - Belarus Q4 2014BMI View: The Belarusian market will suffer from the impact of prolonged rouble depreciation andeconomic instability. ...
Belarus Pharmaceuticals and Helathcare Report Q3 2012 by BMI Research
BMI View: The short-term outlook for the Belarusian pharmaceutical market is deeply uncertain due toexchange-rate volatility and the economy’s lack of capacity for progress without ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!